So that is Cornell's opinion, are there any other points of view?
- Date added:
- Monday, 17 November 2008
- Last revised:
- never
- Hits:
- 3055
- Rating:
- Vote for this:
-
- 
- favoured:
-
0
Answer
The consensus arrived at the seminar sponsored by the Winn
Foundation on FIP/FECV is that the enhanced disease effect is a laboratory
phenomenon, especially since that study by Cornell only used seropositive
cats in the first place.